Shire gets favorable ruling against Allergan in Lialda patent case

(Reuters) - A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States until 2020.

http://ift.tt/1ZGApd9

from Reuters: Health News
via animenewspro